Clinical Trial Update: Carbidopa-levodopa in Neovascular AMD [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating carbidopa-levodopa for neovascular age-related macular degeneration has completed, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration

Drugs mentioned

• carbidopa-levodopa (carbidopa-levodopa)

Snippet

Sponsor: Snyder, Robert W., M.D., Ph.D., P.C. | Conditions: Age-related Macular Degeneration | Phase 2 | Status: COMPLETED | Results posted: 2025-09-12